Biotech

All Articles

GSK's long-acting bronchial asthma medicine cut in half assaults in phase 3

.GSK's long-acting asthma treatment has been revealed to cut in half the amount of strikes in a set ...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival fall short

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has neglected ...

Roivant reveals new 'vant' to advance Bayer hypertension med

.Matt Gline is actually back along with a brand new 'vant' firm, after the Roivant Sciences CEO paid...

Viridian eye disease phase 3 favorites, advancing push to rivalrous Amgen

.Viridian Therapies' stage 3 thyroid eye ailment (TED) clinical trial has struck its own key as well...

Bain unveils $3B fund permanently scientific research providers

.Along with a sturdy track record for determining diamonds in the rough, Bain Funds Life Sciences (B...

Genentech's cancer cells restructure made 'for scientific main reasons'

.The current selection to combine Genentech's 2 cancer cells divisions was actually produced "clinic...

Tern dental GLP-1 presents 5% weight-loss at 1 month at best dose

.Terns Pharmaceuticals' choice to drop its liver illness passions may however settle, after the biot...

Merck, Daiichi regular early results in tiny tissue lung cancer cells with updated ADC records

.Merck &amp Co.'s long-running initiative to land a punch on small mobile lung cancer (SCLC) has act...

Boehringer, Bayer breakthrough lung cancer cells drugs towards Astra battle

.Some people along with non-small cell bronchi cancer (NSCLC) possess mutations in a genetics named ...

MBX aims for $136M IPO to take rival to Ascendis in to stage 3

.MBX has fleshed out programs to take in over $136 thousand from its IPO as the biotech hopes to car...